Companies: | 51,220 |
Products and Services: | 2,879 |
Articles and publications: | 31,561 (+3) |
Tenders & Vacancies: | 17 |
Natural Biomaterials Market: Overview
· Natural biomaterials are taken from plants or animals and are used to replace, augment, or repair body tissues and organs
· The global natural biomaterial market is likely to expand at a rapid pace in the next few years. Increase in investment in research and development of precision medicine and molecular biology is the key factor augmenting the market. Rise in geriatric population that is prone to various chronic diseases is another factor boosting the demand for natural biomaterials. Growth in usage of biomaterial science in various advanced medical technologies, such as drug delivery devices, plastic surgery, tissue engineering, and other medical implants, is expected to propel the market in the near future.
Request A Sample- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=64095
Key Drivers and Restraints of Natural Biomaterials Market
· Advancements in tissue designing and increase in number of knee and hip replacement surgeries have created lucrative opportunities for the global natural biomaterials market. Extensive research and development activities supported by key players to develop advanced biomaterial products is also anticipated to boost the market. However, lack of reimbursement policies and inadequate supply of natural tissues are estimated to restrain the global natural biomaterials market. Difficulties relating to biocompatibility of biomaterials with living tissues are also projected to hamper the market in the near future.
Natural Biomaterials Market: Segments
· The global natural biomaterial market can be segmented based on product type, application, and region
· Based on product type, the market can be divided into fibrin, hyaluronic acid collagen, cellulose, gelatin, alginate, chitin/chitosan, and silk
· Based on application, the global natural biomaterials market can be segregated into regenerative medicine, gene therapy, immunotherapy, stem-cell therapy, tissue engineering, and others
Purchase A Report- https://www.transparencymarketresearch.com/checkout.php?rep_id=64095<ype=S
COVID-19 Impact on Natural Biomaterials Market
· Emergence of the new COVID strain in many developed and developing countries has adversely affected the health care infrastructure. Hospital staff, medicines, oxygen beds, and ventilators are in short supply. Supply chains are facing disruptions, leading to disturbances in production activities in many countries. This is adversely affecting the global natural biomaterials market.
· On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 213 countries and territories around the world.
North America to Dominate Natural Biomaterials Market
· In terms of geography, the global natural biomaterials market can be split into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa
· North America is expected to hold major share of the global market during the forecast period. Growth in prevalence of cardiovascular diseases, increase in investments in the health care industry, and rise in bio-based research are the key factors driving the demand for natural biomaterials in North America.
· The market in Asia Pacific is likely to expand considerably in the near future. China and India are experiencing high number of plastic surgeries. This is likely to augment the global natural biomaterials market in these countries.
Key Manufacturers Operating in Global Natural Biomaterials
· Leading players are focusing on employing innovative products through research and development activities. This would provide players with an edge against their competitors and help them expand their footprint in the market.
· Key players are also collaborating with new entrants and regional vendors to expand their reach in untapped markets. For instance, a subsidiary firm of Invibio Biomaterial Solutions, Invibio Knee Ltd., collaborated with Maxx Orthopedics Inc. and developed PEEK-OPTIMA femoral knee replacement. This collaboration is anticipated to strengthen the company’s position in the market.